| | Business Summary | | Beckman
Coulter,
Inc.
simplifies
and
automates
laboratory
processes
used
in
all
phases
of
the
battle
against
disease.
The
Company
designs,
manufactures
and
markets
systems
that
consist
of
instruments,
chemistries,
software
and
supplies
that
meet
a
variety
of
laboratory
needs.
The
Company's
products
are
used
in
a
range
of
applications,
from
instruments
used
for
pioneering
medical
research,
clinical
trials
and
drug
discovery,
to
diagnostic
tools
found
in
hospitals
and
physicians'
offices.
Beckman
Coulter's
product
lines
include
virtually
all
blood
tests
routinely
performed
in
hospital
laboratories
and
a
range
of
systems
for
medical
and
pharmaceutical
research.
The
Company
has
more
than
125,000
systems
operating
in
laboratories
around
the
world,
with
approximately
two-thirds
of
annual
revenues
coming
from
after-market
customer
purchases
of
operating
supplies,
chemistry
kits
and
service.
Beckman
Coulter
markets
its
products
in
approximately
130
countries. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | BEC
simplifies
and
automates
laboratory
processes
used
in
all
phases
of
the
battle
against
disease.
BEC
designs,
manufactures
and
markets
systems
which
consist
of
instruments,
chemistries,
software
and
supplies
that
meet
a
variety
of
laboratory
needs.
For
the
six
months
ended
6/01,
revenues
rose
3%
to
$929.1
million.
Net
income
before
acct'g
change
rose
13%
to
$60.2
million.
Results
reflect
sales
growth
at
routine
chemistry
and
robotic
analysis,
and
debt
reduction. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| John Wareham, 59
Chairman,
Pres, COO | $1.4M | -- | Amin Khalifa, 47
CFO,
VP | 438K | -- | Edgar Vivanco, 57
Sr.
VP, Diagnostics Devel. and Corp. Manufacturing | 431K | -- | Albert Ziegler, 62
Sr.
VP, Diagnostics Commercial Operations | 506K | $586K | James Glover, 51
VP,
Treasurer | -- | -- | | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/b/bec.gif)